RedHill Biopharma reported $22.29M in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
Cronos Group USD 41.07M 3.45M Sep/2025
RedHill Biopharma USD 22.29M 64K Jun/2025